Celldex Therapeutics CLDX Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$258.76M-63.9% | -$157.86M-11.6% | -$141.43M-25.9% | -$112.33M-59.3% | ||
| $3.38M+6.4% | $3.18M+5.6% | $3.01M+3.9% | $2.9M-5.6% | ||
| $36.22M+5.8% | $34.24M+43.3% | $23.89M+53.0% | $15.61M+74.4% | ||
| -$210.95M-33.7% | -$157.78M-47.1% | -$107.29M-3.4% | -$103.73M-70.3% | ||
| $2.71M+41.4% | $1.92M+5.6% | $1.82M-0.5% | $1.83M+46.4% | ||
| $209.07M— | —— | -$105.78M-218% | $89.94M+142% | ||
| $2.39M-99.5% | $441.45M+102% | $218.46M+5,260% | $4.08M-98.5% | ||
| —— | —— | $5.39M— | —— | ||
| -$213.66M-33.8% | -$159.7M-46.4% | -$109.11M-3.4% | -$105.56M-69.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Celldex Therapeutics generate?
- Celldex Therapeutics (CLDX) generated -$222.2M in operating cash flow over the trailing twelve months.
- What is Celldex Therapeutics's free cash flow?
- After $4.1M of capital expenditures, Celldex Therapeutics's free cash flow was -$226.2M over the trailing twelve months, down 30.5% year over year.
- Where does Celldex Therapeutics's cash flow data come from?
- Every line is extracted from Celldex Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
